Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 505-511

  Otsuka, Fumiyuki ^a   Hibi, Kiyoshi ^a   Kusama, Ikuyoshi ^a   Endo, Mitsuaki ^a   Kosuge, Masami ^a   Iwahashi, Noriaki ^a   Okuda, Jun ^a   Tsukahara, Kengo ^a   Ebina, Toshiaki ^a   Kojima, Sunao ^b   Sugiyama, Seigo ^b   Ogawa, Hisao ^b   Umemura, Satoshi ^c   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Intravascular ultrasound; Plaque rupture; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY PLAQUE RUPTURE; CORONARY RISK; FEMALE; GENDER; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS;

EID: 78649754965     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.005     Document Type: Article

References (32)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389.
2. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995, 333:1301-1307.
3. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001, 285:1711-1718.
4. Colhoun H.M., Betteridge D.J., Durrington P.N., et al. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia 2005, 48:2482-2485.
5. Schartl M., Bocksch W., Koschyk D.H., et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001, 104:387-392.
6. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
7. Fukumoto Y., Libby P., Rabkin E., et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001, 103:993-999.
8. Bustos C., Hernandez-Presa M.A., Ortego M., et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998, 32:2057-2064.
9. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
10. Kusama I., Hibi K., Kosuge M., et al. Impact of plaque rupture on infarct size in ST-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol 2007, 50:1230-1237.
11. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Thrombolysis in myocardial ischemia. Circulation 1994, 89:1545-1556.
12. Rentrop K.P., Cohen M., Blanke H., Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5:587-592.
13. Sano T., Tanaka A., Namba M., et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 2003, 108:282-285.
14. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998, 97:2302-2306.
15. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition. Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:1478-1492.
16. Hibi K., Ward M.R., Honda Y., et al. Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 2005, 65:233-239.
17. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005, 45:1946-1953.
18. Takarada S., Imanishi T., Kubo T., et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 2009, 202:491-497.
19. Johnson J., Carson K., Williams H., et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005, 111:1422-1430.
20. Schoenhagen P., Ziada K.M., Kapadia S.R., Crowe T.D., Nissen S.E., Tuzcu E.M. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000, 101:598-603.
21. Varnava A.M., Mills P.G., Davies M.J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002, 105:939-943.
22. Schoenhagen P., Tuzcu E.M., Apperson-Hansen C., et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006, 113:2826-2834.
23. Hong M.K., Mintz G.S., Lee C.W., et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004, 110:928-933.
24. Albert M.A., Danielson E., Rifai N., Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001, 286:64-70.
25. Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002, 105:2019-2023.
26. Tardif J.C., Gregoire J., L'Allier P.L., et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 2007, 297:1675-1682.
27. Fernandez-Ortiz A., Badimon J.J., Falk E., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994, 23:1562-1569.
28. Iwakura K., Ito H., Kawano S., et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J 2006, 27:534-539.
29. Spencer F.A., Allegrone J., Goldberg R.J., et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 2004, 140:857-866.
30. Hayashi T., Kiyoshima T., Matsuura M., et al. Plaque erosion in the culprit lesion is prone to develop a smaller myocardial infarction size compared with plaque rupture. Am Heart J 2005, 149:284-290.
31. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
32. Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core, a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996, 93:1354-1363.